protein tyrosine kinase inhibitor therapy

PROCEDURE4 trials

Sponsors

Eastern Cooperative Oncology Group, University of Rochester, Barbara Ann Karmanos Cancer Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions

Colorectal CancerEsophageal CancerGastrointestinal Carcinoid TumorIslet Cell CarcinomaNon-small Cell Lung Cancer

Phase 1

Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

WithdrawnNCT00268255

Barbara Ann Karmanos Cancer InstituteNon-small Cell Lung Cancer

Updated: 2013-04-16

Phase 2

Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors

WithdrawnNCT00227773

Eastern Cooperative Oncology GroupGastrointestinal Carcinoid Tumor, Islet Cell Carcinoma

Updated: 2015-10-08

Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery

TerminatedNCT00258297

University of RochesterEsophageal Cancer

Start: 2004-04-30End: 2006-11-30Target: 30Updated: 2013-10-16

Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy

TerminatedNCT00390364

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsColorectal Cancer

Start: 2006-10-31End: 2007-10-31Updated: 2014-10-08